Klotho Neurosciences to acquire select assets from Turn Biotechnologies [Seeking Alpha]
Klotho Neurosciences, Inc. (KLTO)
Company Research
Source: Seeking Alpha
Under the LOI, Klotho would acquire Turn's ERA ("Epigenetic Reprogramming of Age") platform and eTurna RNA delivery system. Importantly, as part of this transaction, Klotho will be acquiring a signed out-licensing and co-development partnership with one of South Korea's leading pharmaceutical companies worth up to $300 million. More on Klotho Neurosciences, Inc. Financial information for Klotho Neurosciences, Inc.
Show less
Read more
Impact Snapshot
Event Time:
KLTO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KLTO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KLTO alerts
High impacting Klotho Neurosciences, Inc. news events
Weekly update
A roundup of the hottest topics
KLTO
News
- Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' AwardPR Newswire
- Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in BostonPR Newswire
- Klotho Neurosciences Announces Expiration of Letter of Intent [Yahoo! Finance]Yahoo! Finance
- Klotho Neurosciences Announces Expiration of Letter of IntentPR Newswire
- Klotho to acquire Turn Biotechnologies' assets [Yahoo! Finance]Yahoo! Finance
KLTO
Sec Filings
- 11/13/25 - Form 10-Q
- 11/6/25 - Form S-8
- 9/30/25 - Form 424B3
- KLTO's page on the SEC website